In the News

A new study is challenging the perception that mesothelioma affects only older men. Learn why MSK experts say the medical community should be aware of this rare cancer's early symptoms.

Human data and results from mouse experiments suggest that people with BRCA2 mutations may respond well to immunotherapy drugs.

Learn the keys to a successful telemedicine visit from a cancer specialist at Memorial Sloan Kettering.

New MSK research identifies a rare cell population responsible for AML persistence and resistance to therapy; sheds new light on early brain development; and investigates how other health conditions can increase cancer risk in midlife. MSK clinical trials also supported the recent approval of the targeted drug larotrectinib by the FDA.

Memorial Sloan Kettering is sad to note the passing on May 12 of Stephen Sternberg, at the age of 100. Dr. Sternberg spent his entire career at MSK as a surgical pathologist. Widely known as a leader in the field of pathology and highly regarded for his expertise, he was also greatly respected as an editor of major national publications, which garnered him a broad, devoted following around the world.

Cards are a longstanding Valentine’s tradition — and The Scarlett Fund, with help from Memorial Sloan Kettering Cancer Center employees, is using cards to make sure that patients and staff will be feeling the love for a long time to come.

At Memorial Sloan Kettering Cancer Center’s 45th annual ceremony, graduating master's and PhD students were honored and award winners were recognized.